Dine Brands Global, Inc. to Release Third Quarter 2026 Earnings on November 4, 2026
The restaurant operator will discuss third-quarter 2026 results and business outlook on an 11:00 a.m. ET call with webcast replay available.
- Dine Brands Global, parent of Applebee's Neighborhood Grill + Bar, IHOP, and Fuzzy's Taco Shop, will announce third quarter 2026 financial results on November 4, 2026, before the stock market opens.
- As of June 28, 2026, Dine Brands supported nearly 3,500 restaurants across its brands; the company ranks among the world's largest full-service restaurant operators after expanding into the Fast Casual segment in 2022.
- Executives will host a conference call at 11:00 a.m. Eastern Time on November 4, 2026, to discuss results; participants are encouraged to dial in fifteen minutes early to avoid delays.
- Separately, Novanta, a technology partner to medical and advanced industrial manufacturers, will release third quarter 2026 results after markets close on November 9, 2026, and will host a conference call on November 10, 2026.
- Interested parties can access the Novanta conference call by dialing 346-3959 or via live webcast; the firm attributes growth to "team of innovative professionals" committed to the Novanta Growth System.
11 Articles
11 Articles
Financial Post
Novanta Inc. Announces Schedule of Third Quarter 2026 Earnings Release and Conference Call
BOSTON — Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2026 results after the close of U.S. financial markets on Monday, November 9, 2026. The Company will host a conference call on Tuesday, November 10, 2026 at 8:00 a.m. ET to […]
SharkNinja Announces Third Quarter 2026 Earnings Release and Conference Call Date
NEEDHAM, Mass.--(BUSINESS WIRE)--SharkNinja, Inc. (NYSE: SN), a leading global product design and technology company, today announced that its financial results for the third quarter 2026 will be released on Wednesday, November 4, 2026 before market open. The Company will host a live earnings conference call and webcast at 8:30 a.m. Eastern Time that same day. The link to the webcast will be available on the Investor Relations section of the Com…
Globus Medical Schedules Third Quarter Earnings Release and Conference Call – Ortho Spine News
AUDUBON, Pa., Oct. 13, 2026 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the third quarter ended September 30, 2026 after the market close on Thursday, November 5, 2026. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com. Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Participants may access the conference call live via webcast on the Investors page of Globus Medical’s website at https://www.investors.globusmedical.com/news-events/events-webcasts. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. The audio archive will be available after the call on the Investors page of the Globus Medical website. About Globus Medical, Inc.Globus Medical, Inc. is a leading global musculoskeletal technology company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. Additional information can be accessed at www.globusmedical.com. Safe Harbor StatementsAll statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, the risks and costs associated with health epidemics, pandemics and similar outbreaks, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with laws and regulations that are or may become applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, the successful integration of businesses that we have acquired or may acquire in the future, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, refer to the disclosures contained in our most recent Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”), including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our subsequent filings with the SEC. These documents are available at www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time, and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. Except as may be required by applicable law, we undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof. As used herein, the “Company”, “Globus”, “Globus Medical”, “we”, “us”, and “our” refers to Globus Medical, Inc. Contact Shagun SinghSenior Vice President, Strategy and Investor Relations(610) 930-1800investors@globusmedical.com
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
